A Study of Picankibart in Patients With Active Psoriatic Arthritis
Clinical trial NCT07295509 · RECRUITING
Trial details
- NCT number
- NCT07295509
- Sponsor
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-18
- Primary completion
- 2029-12-31
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.